Digitisation | April 14, 2026
Imagene AI teams up with Daiichi Sankyo to supercharge cancer drug development
A major push to sharpen the future of cancer treatment is underway
A major push to sharpen the future of cancer treatment is underway
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect
The new capital is expected to fund the company through 2029
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
SNV4818, the oral drug, is pan-mutant–selective PI3K? inhibitor aimed at treating HR+/HER2- breast cancer and potentially other solid tumors
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
Esprit is a multicenter, randomized, placebo-controlled, double-blind study assessing the safety, pharmacodynamics, and preliminary efficacy of S-606001 as a substrate reduction therapy
Subscribe To Our Newsletter & Stay Updated
